FY2025 EPS Forecast for Varonis Systems Reduced by Analyst

Varonis Systems, Inc. (NASDAQ:VRNS) – Analysts at Cantor Fitzgerald lowered their FY2025 earnings estimates for Varonis Systems in a research note issued on Thursday, September 4th. Cantor Fitzgerald analyst J. Ruykhaver now forecasts that the technology company will post earnings of ($0.91) per share for the year, down from their previous forecast of ($0.84). Cantor Fitzgerald has a “Overweight” rating and a $60.00 price objective on the stock. The consensus estimate for Varonis Systems’ current full-year earnings is ($0.83) per share. Cantor Fitzgerald also issued estimates for Varonis Systems’ FY2026 earnings at ($0.73) EPS.

VRNS has been the topic of several other reports. DA Davidson lifted their price target on shares of Varonis Systems from $47.00 to $50.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 30th. Wells Fargo & Company raised shares of Varonis Systems from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $51.00 to $70.00 in a research note on Monday, August 11th. Susquehanna lifted their price target on shares of Varonis Systems from $55.00 to $65.00 and gave the stock a “positive” rating in a research note on Wednesday, July 30th. Robert W. Baird upped their price target on shares of Varonis Systems from $58.00 to $63.00 and gave the company an “outperform” rating in a report on Wednesday, July 30th. Finally, Morgan Stanley upped their price target on shares of Varonis Systems from $59.00 to $66.00 and gave the company an “overweight” rating in a report on Tuesday, September 2nd. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $61.65.

Varonis Systems Trading Down 0.4%

VRNS stock opened at $57.36 on Monday. The company has a market capitalization of $6.43 billion, a PE ratio of -62.35 and a beta of 0.67. Varonis Systems has a one year low of $36.53 and a one year high of $60.58. The company’s 50 day moving average price is $54.88 and its two-hundred day moving average price is $47.96. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.38 and a current ratio of 1.38.

Varonis Systems (NASDAQ:VRNS) last announced its earnings results on Tuesday, July 29th. The technology company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.02. The business had revenue of $152.16 million during the quarter, compared to analyst estimates of $147.80 million. Varonis Systems had a negative net margin of 17.30% and a negative return on equity of 23.06%. Varonis Systems’s revenue for the quarter was up 16.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.05 earnings per share. Varonis Systems has set its FY 2025 guidance at 0.160-0.180 EPS. Q3 2025 guidance at 0.070-0.080 EPS.

Insiders Place Their Bets

In other Varonis Systems news, Director Den Bosch Fred Van sold 3,000 shares of the business’s stock in a transaction on Friday, August 1st. The shares were sold at an average price of $55.08, for a total transaction of $165,240.00. Following the transaction, the director directly owned 128,666 shares of the company’s stock, valued at approximately $7,086,923.28. The trade was a 2.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Guy Melamed sold 51,889 shares of the business’s stock in a transaction on Friday, August 1st. The shares were sold at an average price of $55.10, for a total transaction of $2,859,083.90. Following the transaction, the chief financial officer directly owned 470,602 shares in the company, valued at approximately $25,930,170.20. The trade was a 9.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 113,386 shares of company stock worth $6,429,405. Insiders own 2.30% of the company’s stock.

Institutional Trading of Varonis Systems

A number of hedge funds and other institutional investors have recently modified their holdings of VRNS. Captrust Financial Advisors grew its position in shares of Varonis Systems by 66.6% in the 4th quarter. Captrust Financial Advisors now owns 13,765 shares of the technology company’s stock worth $612,000 after buying an additional 5,502 shares during the period. Deutsche Bank AG grew its position in shares of Varonis Systems by 97.7% in the 4th quarter. Deutsche Bank AG now owns 1,338,452 shares of the technology company’s stock worth $59,467,000 after buying an additional 661,436 shares during the period. Ensign Peak Advisors Inc grew its position in shares of Varonis Systems by 11.8% in the 4th quarter. Ensign Peak Advisors Inc now owns 51,230 shares of the technology company’s stock worth $2,276,000 after buying an additional 5,419 shares during the period. Graham Capital Management L.P. grew its position in shares of Varonis Systems by 207.3% in the 4th quarter. Graham Capital Management L.P. now owns 31,894 shares of the technology company’s stock worth $1,417,000 after buying an additional 21,514 shares during the period. Finally, Occudo Quantitative Strategies LP grew its position in shares of Varonis Systems by 5.2% in the 4th quarter. Occudo Quantitative Strategies LP now owns 10,871 shares of the technology company’s stock worth $483,000 after buying an additional 540 shares during the period. 95.65% of the stock is owned by hedge funds and other institutional investors.

About Varonis Systems

Varonis Systems, Inc provides software products and services that allow enterprises to manage, analyze, alert, and secure enterprise data in North America, Europe, the Middle East, Africa, and internationally. Its software enables enterprises to protect data stored on premises and in the cloud, including sensitive files and emails; confidential personal data belonging to customers, and patients and employees' data; financial records; source code, strategic and product plans; and other intellectual property.